Postpartum hemorrhage (PPH) is the leading cause of maternal morbidity and mortality worldwide. Disparities in PPH‐associated survival between high and low‐/middle‐income countries reflect an imperative for low‐resource countries to improve strategies for rapid diagnosis and treatment. A review of current PPH diagnosis, prevention, treatment, and access to care in low‐income countries has been used to understand, extract, and report the challenges that public health systems face in trying to solve the marked global disparity in PPH outcomes. Improvement in PPH survival begins with holistic strengthening of each step along the continuum of care in health systems and should include performance feedback measures and quality‐of‐care research.

Objective: To evaluate the impact of introducing a uterine balloon tamponade (ESM-UBT) device for managing severe postpartum hemorrhage (PPH), mainly due to uterine atony, in health facilities in India on the rates of PPH-related maternal death and invasive procedures for PPH control. Methods:We used a quasi-experimental, difference-in-difference (DID) design to compare changes in the rates of a composite outcome (PPH-related maternal death and/or artery ligation, uterine compression sutures, or hysterectomy) among women delivering in nine intervention facilities compared with those delivering in two control facilities, before and after the introduction of ESM-UBT. Results:The study sample included 214 123 deliveries (n = 78 509 before ESM-UBT introduction; n = 47 211 during ESM-UBT introduction; and n = 88 403 after ESM-UBT introduction). After introduction of ESM-UBT, there was a significant decline in the rate of the primary composite outcome in intervention facilities (21.0-11.4 per 10 000 deliveries; difference −9.6, 95% confidence interval −14.0 to −5.4).

Aim: This study aims to explore the patient's experience with telemedicine (TM) as a method of care as well as its long-term implications for the Department of Obstetrics and Gynecology during the COVID-19 pandemic. Methods: Telephonic interview was conducted for 78 patients who had availed TM services from April 23, 2020, to June 30, 2020. A predetermined indigenous questionnaire was used to evaluate patient's experiences with TM. Primary outcome was the measurement of level of patient satisfaction and secondary outcome was evaluating the demographic profile of patients. Results: Most respondents were of 21-30 years (42.3%) and 64.1% of respondents were from urban areas. 87.1% respondents were satisfied with the medical care they received; 94.8% respondents did not feel that their doctors hurried through their consultation. 19.2% respondents had encountered difficulty in using smartphones. 70.5% respondents perceived a positive role of TM in reducing their risk of contracting COVID-19. 62.8% respondents showed willingness to continue using TM services after the resumption of routine OPD services. 76.9% respondents felt that currently provided TM services did not need any improvements. 25.6% respondents needed physical visits to doctors even after availing TM services, for routine or emergency complaints. Conclusion: Patient satisfaction is high with TM services, and it can be adopted and incorporated into routine patient care especially in lowresource countries. Clinical significance: TM is expected to increase access to healthcare, while limiting patients' geographic mobility. The implications and full potential of this service will be clear with long-term studies.

No abstract